GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bright Minds Biosciences Inc (XCNQ:DRUG) » Definitions » Market Cap

Bright Minds Biosciences (XCNQ:DRUG) Market Cap : C$367.56 Mil (As of Apr. 01, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Bright Minds Biosciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bright Minds Biosciences's share price for the quarter that ended in Dec. 2024 was C$51.6. Bright Minds Biosciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 6.99 Mil. Therefore, Bright Minds Biosciences's market cap for the quarter that ended in Dec. 2024 was C$360.63 Mil.

Bright Minds Biosciences's quarterly market cap increased from Jun. 2024 (C$6.16 Mil) to Sep. 2024 (C$6.65 Mil) and increased from Sep. 2024 (C$6.65 Mil) to Dec. 2024 (C$360.63 Mil).

Bright Minds Biosciences's annual market cap declined from Sep. 2022 (C$29.90 Mil) to Sep. 2023 (C$8.11 Mil) and declined from Sep. 2023 (C$8.11 Mil) to Sep. 2024 (C$6.65 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bright Minds Biosciences's Enterprise Value for Today is C$309.84 Mil.


Bright Minds Biosciences Market Cap Historical Data

The historical data trend for Bright Minds Biosciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Minds Biosciences Market Cap Chart

Bright Minds Biosciences Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Market Cap
- 106.99 29.90 8.11 6.65

Bright Minds Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.46 6.61 6.16 6.65 360.63

Competitive Comparison of Bright Minds Biosciences's Market Cap

For the Biotechnology subindustry, Bright Minds Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bright Minds Biosciences's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bright Minds Biosciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Bright Minds Biosciences's Market Cap falls into.


;
;

Bright Minds Biosciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Bright Minds Biosciences's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as

Market Cap (A: Sep. 2024 )=Share Price (A: Sep. 2024 )*Shares Outstanding (EOP) (A: Sep. 2024 )
=C$1.47*4.524
=C$6.65

Bright Minds Biosciences's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=C$51.6*6.989
=C$360.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bright Minds Biosciences  (XCNQ:DRUG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Bright Minds Biosciences Market Cap Related Terms

Thank you for viewing the detailed overview of Bright Minds Biosciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Bright Minds Biosciences Business Description

Traded in Other Exchanges
Address
19 Vestry Street, New York, NY, USA, 10013
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Executives
Jan Torleif Pedersen Director
Ryan Cheung Senior Officer
Nils Bottler Director
Jeremy Fryzuk Director
Alan Kozikowski 10% Security Holder, Director, Senior Officer
Ian Mcdonald Director